Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Aceragen

    Client Virtual Booth

    ACERAGEN

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Aceragen
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    15 TW Alexander Drive Durham, NC 27709
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aceragen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aceragen/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Aceragen, Inc. to Delist from The Nasdaq Stock Market
    Aceragen, Inc. to Delist from The Nasdaq Stock Market

    https://www.globenewswire.com/news-release/2023/08/04/2719284/33448/en/Aceragen-Inc-to-Delist-from-The-Nasdaq-Stock-Market.html

    GLOBENEWSWIRE
    04 Aug 2023
    Share Share
    Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
    Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing

    https://www.globenewswire.com/news-release/2023/05/30/2678854/33448/en/Aceragen-Inc-Receives-Nasdaq-Notice-Regarding-Delayed-Form-10-Q-Filing.html

    GLOBENEWSWIRE
    30 May 2023
    Share Share
    Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study
    Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study

    https://www.globenewswire.com/news-release/2023/02/06/2602192/33448/en/Aceragen-Announces-Recommendation-of-Data-Monitoring-Committee-in-Terra-Study.html

    GLOBENEWSWIRE
    06 Feb 2023
    Share Share
    Aeterna discontinues vaccine development; Idera rebrands as Aceragen
    Aeterna discontinues vaccine development; Idera rebrands as Aceragen

    https://endpts.com/aeterna-discontinues-vaccine-development-idera-rebrands-as-aceragen/

    Paul Schloesser ENDPTS
    17 Jan 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search